story of the week
Rucaparib vs Physician's Choice Therapy for Metastatic Prostate Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The New England Journal of Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Rucaparib or Physician's Choice in Metastatic Prostate Cancer
N. Engl. J. Med 2023 Feb 23;388(8)719-732, K Fizazi, JM Piulats, MN Reaume, P Ostler, R McDermott, JR Gingerich, E Pintus, SS Sridhar, RM Bambury, U Emmenegger, H Lindberg, D Morris, F Nolè, J Staffurth, C Redfern, MI Sáez, W Abida, G Daugaard, A Heidenreich, L Krieger, B Sautois, A Loehr, D Despain, CA Heyes, SP Watkins, S Chowdhury, CJ Ryan, AH BryceFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Advanced Prostate Cancer Center of Excellence
Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.